Literature DB >> 8162013

Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families.

S Imbeaud1, D Carré-Eusèbe, R Rey, C Belville, N Josso, J Y Picard.   

Abstract

A rare form of familial male pseudohermaphroditism, the persistent Müllerian duct syndrome (PMDS) is characterized by persistence of uterus and Fallopian tubes in 46,XY phenotypic males and is ascribed to defects in the synthesis or action of anti-Müllerian hormone (AMH). Biologically, PMDS is heterogeneous: in some cases, bioactive AMH is normally expressed by testicular tissue while, in others, no AMH is produced, suggesting the possibility of an AMH gene mutation, several of which have already been described. Molecular analysis of the AMH gene has now been performed in 21 additional patients and their families. In 6 patients, with normal serum concentration of AMH, the AMH gene was normal or contained only polymorphisms and silent mutations, supporting the hypothesis that the condition is due to end-organ resistance. Nine novel mutations were discovered in the remaining subjects, with low or undetectable levels of serum AMH. These mutations, when present in homozygotes or compound heterozygotes, were associated with the PMDS phenotype, the same mutation never being observed in two different families. The three first exons of the AMH gene appear particularly mutation-prone, although they are less GC rich than the 2 last ones and code for the N-terminal part of the AMH protein, which is not in itself essential to bioactivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162013     DOI: 10.1093/hmg/3.1.125

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  Persistent mullerian duct syndrome with transverse testicular ectopia.

Authors:  Mehmet Emin Boleken; Mete Kaya; Sefik Güran; Mehmet Erdal Memetoğlu; Turan Kanmaz; Selçuk Yücesan
Journal:  Int Urol Nephrol       Date:  2007-03-01       Impact factor: 2.370

Review 2.  Towards improved genetic diagnosis of human differences of sex development.

Authors:  Emmanuèle C Délot; Eric Vilain
Journal:  Nat Rev Genet       Date:  2021-06-03       Impact factor: 53.242

3.  A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Authors:  Takuya Akiyama; Guillermo Marqués; Kristi A Wharton
Journal:  Sci Signal       Date:  2012-04-03       Impact factor: 8.192

Review 4.  Genes involved in testicular development and function.

Authors:  D J Lamb
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  Persistent Mullerian duct syndrome with transverse testicular ectopia and seminoma.

Authors:  Bilal Fırat Alp; Zafer Demirer; Ali Gürağaç; Oğuzhan Babacan; Erkan Sarı; Sebahattin Sarı; Ibrahim Yavan
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

6.  Testicular degeneration in three patients with the persistent müllerian duct syndrome.

Authors:  S Imbeaud; R Rey; P Berta; J L Chaussain; J M Wit; R H Lustig; M A De Vroede; J Y Picard; N Josso
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

7.  Abnormal gonadal differentiation in two subjects with ambiguous genitalia, Mullerian structures, and normally developed testes: evidence for a defect in gonadal ridge development.

Authors:  J S Fuqua; E S Sher; E J Perlman; M D Urban; M Ghahremani; J Pelletier; C J Migeon; T R Brown; G D Berkovitz
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

8.  Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.

Authors:  R Rey; L al-Attar; F Louis; F Jaubert; P Barbet; C Nihoul-Fékété; J L Chaussain; N Josso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

9.  Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.

Authors:  Thanos D Papakostas; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Aristomenis Thanos; George Trichonas; Xanthi Koufomichali; Kosisochukwu Anago; Patricia K Donahoe; Jose Teixeira; David T MacLaughlin; Demetrios Vavvas
Journal:  Protein Expr Purif       Date:  2009-09-13       Impact factor: 1.650

Review 10.  At the Crossroads of Fate-Somatic Cell Lineage Specification in the Fetal Gonad.

Authors:  Emmi Rotgers; Anne Jørgensen; Humphrey Hung-Chang Yao
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.